News | Radiation Therapy | January 04, 2016

ASTRO Applauds Congress for Freezing Freestanding Radiation Oncology Center Payment Rates

Passage of S.2425 maintains 2017-2018 rates at levels set under 2016 Medicare Physician Fee Schedule

January 4, 2016 – The American Society for Radiation Oncology (ASTRO) applauded Congress for its passage of S. 2425 to freeze radiation oncology freestanding center payment rates for 2017-2018 at the levels set under the Medicare Physician Fee Schedule for 2016. ASTRO voiced its appreciation for bipartisan, bicameral leadership in Congress for their continued efforts to ensure rates for radiation oncology services provide the stability necessary to avoid any disruptions in critical cancer care. The society said the passage of S.2425 reinforced Congress’ acknowledgement that continued cuts to community-based radiation therapy centers could disrupt critical services that cancer patients rely upon.

Radiation oncology reimbursement rates have sustained significant cuts in recent years, which has resulted in cumulative payment reductions totaling approximately 20 percent for freestanding cancer centers. Passage of this legislation will help create a more stable environment during which ASTRO and other radiation oncology stakeholders can continue to work with the Centers for Medicare & Medicaid Services on radiation treatment delivery coding and valuation issues, as well as the development of radiation oncology-specific alternative payment models.

Bruce D. Minsky, M.D., FASTRO and ASTRO chair, said, “ASTRO thanks radiation oncology’s champions in Congress for ensuring patient access to community-based cancer care nationwide. ASTRO looks forward to continuing to work with Congress and CMS to protect cancer patient access to care, and we appreciate the stability this legislation provides for freestanding cancer treatment centers.”

For more information:

Related Content

More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study Achieved With Accuray Precision

Image courtesy of Accuray Inc.

News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Geraldine McGinty Elected First Female Chair of American College of Radiology

Image courtesy of the American College of Radiology

News | Radiology Business | May 22, 2018
The American College of Radiology (ACR) Board of Chancellors has elected Geraldine McGinty, M.D., MBA, FACR, as chair....
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
Joint ACR-SIIM Summit to Examine Economics of AI in Healthcare
News | Artificial Intelligence | May 15, 2018
On May 30, 2018, the American College of Radiology (ACR) Data Science Institute (DSI) and the Society for Imaging...
ITN Wins Two 2018 National Azbee Awards for Editorial Excellence
News | Radiology Business | May 14, 2018
Imaging Technology News (ITN) was honored with a pair of National Bronze Azbee Awards for editorial excellence at the...
In today’s world of flashy new features and complicated equipment, we must remember to stop and ask ourselves, “What is this doing for the patient?”

Image courtesy of Carestream.

Feature | Radiology Business | May 03, 2018 | By Jennifer Kemp, M.D., FACR
As a radiologist in today’s evolving global healthcare landscape, I’m grateful for the innovations in...
Esaote Change of Ownership Completed
News | Ultrasound Imaging | April 30, 2018
The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company...
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
Overlay Init